Brief: Gyre Therapeutics Completes Acquisition Of Cullgen To Create U.S.- And China-Based Fully Integrated Biopharmaceutical Company
04/05/2026 13:49
May 4 (Reuters) - Gyre Therapeutics Inc GYRE.O: GYRE THERAPEUTICS COMPLETES ACQUISITION OF CULLGEN TO CREATE U.S.- AND CHINA-BASED FULLY INTEGRATED BIOPHARMACEUTICAL COMPANY Source text: ID:nGNX9nVvYN Further company coverage: GYRE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gyre Therapeutics
See all newsBrief: Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
Gyre Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Gyre Therapeutics, Inc. expected to post a loss of 13 cents a share - Earnings Preview
Brief: Gyre Therapeutics Reports Second Quarter 2026
Gyre Therapeutics Q2 revenue beats estimates on higher ETUARY sales volumes